SOLENO THERAPEUTICS INC
Software platform and clinical decision support system for neonatal jaundice management
- Sector
- Digital health
- Headquarters
- REDWOOD CITY, CA
- Latest Form D
- $60M, Oct 2023
- Total capital
- $97.6M
- Federal grants
- $2.3M
- 3 awards · 2015–2018
- Sector median 0 awards
- Private capital raised
- $95.3M
- 10 Form D · last Oct 2023
- 37 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 10th filing$60M
- Federal grantHealth and Human S · Phase II · Point of Care Breath Test to Screen for Sickle Cell Disease in Developing Nations$1M
- Private capital raisedForm D · SEC · 9th filing$15M
- Federal grantHealth and Human S · Phase II · Point of Care Breath Test to Screen for Sickle Cell Disease in Developing Nations$1.1M
- Private capital raisedForm D · SEC · 8th filing$602K
- Private capital raisedForm D · SEC · 7th filing$3.2M
- Private capital raisedForm D · SEC · 6th filing$4.6M
- Private capital raisedForm D · SEC · 5th filing$1.4M
- Private capital raisedForm D · SEC · 4th filing$3.7M
- Private capital raisedForm D · SEC · 3rd filing$1.9M
- Private capital raisedForm D · SEC · 2nd filing$1.9M
- Private capital raisedForm D · SEC · 1st filing$3.1M
Show 1 earlier federal award
- Federal grantHealth and Human S · Phase I · Point-of-Care End-Tidal Carbon Monoxide Measurement to Screen for Sickle Cell Disease$220K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
Researcher links verified by same-company patents and grants- Anish BhatnagarResearcherExecutive Officer, DirectorLinked by $2.3M in grants as PI
- Andrew SinclairDirectorNamed in SEC Form D filings
- Birgitte VolckDirectorNamed in SEC Form D filings
- Edgar G. EnglemanDirectorNamed in SEC Form D filings
- Ernest MarioDirectorNamed in SEC Form D filings
- Gwen MelincoffDirectorNamed in SEC Form D filings
Show all 15 people
- James MackanessExecutive OfficerNamed in SEC Form D filings
- Jonathan D. WolterExecutive OfficerNamed in SEC Form D filings
- Mahendra D. ShahDirectorNamed in SEC Form D filings
- Matthew PaulsDirectorNamed in SEC Form D filings
- Rajen DalalDirectorNamed in SEC Form D filings
- Steinar EngelsenDirectorNamed in SEC Form D filings
- Stephen N. KirnonDirectorNamed in SEC Form D filings
- Stuart D. CollinsonDirectorNamed in SEC Form D filings
- William G. HarrisDirectorNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- MENTIA DTX ,INC.Similar federal contract value in Digital health · null in contracts
- Kiko Labs IncSimilar federal contract value in Digital health · null in contracts
- LIFE ANALYTICS, INC.Similar federal contract value in Digital health · null in contracts
- ADAPTIVE TECHNOLOGY CONSULTING, LLCSimilar federal contract value in Digital health · null in contracts
- DASION CORPORATIONSimilar federal contract value in Digital health · null in contracts
- K Health, Inc.Similar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .